Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Fätkenheuer

Showing results (1-10 of 234) with videos related to

Pageof 24
Sort By:
Deutsche Medizinische Wochenschrift (1946)|September 25, 2015
[Screening for MRSA: unnecessary, expensive and potentially harmful]Gerd Fätkenheuer
Deutsche Medizinische Wochenschrift (1946)|February 4, 2016
[Asymptomatic bacteriuria]Gerd Fätkenheuer
Infection|November 18, 2025
Language matters: the case of "septic arthritis"Gerd Fätkenheuer
Expert Opinion on Investigational Drugs|October 17, 2013
Lersivirine - a new drug for HIV infection therapyMartin Platten, Gerd Fätkenheuer
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2016
Treatment of Asymptomatic BacteriuriaGerd Fätkenheuer, Norma Jung
HIV Medicine|January 17, 2023
Monkeypox: Lessons from a large cohortGerd Fätkenheuer, Clara Lehmann
Deutsche Medizinische Wochenschrift (1946)|December 4, 2024
[A brief history of infectious diseases - the last 150 years]Bernd Salzberger, Gerd Fätkenheuer
The New England Journal of Medicine|May 16, 2020
Compassionate Use of Remdesivir in Covid-19Gerd Fätkenheuer, Jens Lundgren
The Lancet. Infectious Diseases|September 27, 2017
Combination therapy for bloodstream infections with carbapenemase-producing EnterobacteriaceaeBernd Salzberger, Gerd Fätkenheuer
The Lancet. Infectious Diseases|May 19, 2020
Importance of precise data on SARS-CoV-2 transmission dynamics controlJan Rybniker, Gerd Fätkenheuer
Pageof 24

Showing results (1-10 of 234) with videos related to

Sort By:
Pageof 24
Deutsche Medizinische Wochenschrift (1946)|September 25, 2015
[Screening for MRSA: unnecessary, expensive and potentially harmful]Gerd Fätkenheuer
Deutsche Medizinische Wochenschrift (1946)|February 4, 2016
[Asymptomatic bacteriuria]Gerd Fätkenheuer
Infection|November 18, 2025
Language matters: the case of "septic arthritis"Gerd Fätkenheuer
Expert Opinion on Investigational Drugs|October 17, 2013
Lersivirine - a new drug for HIV infection therapyMartin Platten, Gerd Fätkenheuer
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2016
Treatment of Asymptomatic BacteriuriaGerd Fätkenheuer, Norma Jung
HIV Medicine|January 17, 2023
Monkeypox: Lessons from a large cohortGerd Fätkenheuer, Clara Lehmann
Deutsche Medizinische Wochenschrift (1946)|December 4, 2024
[A brief history of infectious diseases - the last 150 years]Bernd Salzberger, Gerd Fätkenheuer
The New England Journal of Medicine|May 16, 2020
Compassionate Use of Remdesivir in Covid-19Gerd Fätkenheuer, Jens Lundgren
The Lancet. Infectious Diseases|September 27, 2017
Combination therapy for bloodstream infections with carbapenemase-producing EnterobacteriaceaeBernd Salzberger, Gerd Fätkenheuer
The Lancet. Infectious Diseases|May 19, 2020
Importance of precise data on SARS-CoV-2 transmission dynamics controlJan Rybniker, Gerd Fätkenheuer
Pageof 24